New GlaxoSmithKline CEO prepares for R&D choices, potential deals
Go back to New GlaxoSmithKline CEO prepares for R&D choices, potential deals| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 2,937,806 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 150.56 +0.45 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $150.11 | 52 Week High | $108.63 | |||
| Open | $150.11 | 52 Week Low | $71.39 | |||
| Day High | $152.10 | P/E | 83.18 | |||
| Day Low | $148.22 | EPS | $1.81 | |||
| Volume | 5,569,384 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 51.08 +0.86 (1.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.22 | 52 Week High | $45.58 | |||
| Open | $50.75 | 52 Week Low | $37.82 | |||
| Day High | $51.32 | P/E | N/A | |||
| Day Low | $50.46 | EPS | $0.00 | |||
| Volume | 2,872,200 | |||||
| NOVEN PHARMACEUTIC (NASDAQ: NOVN) | Delayed: 0.09 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.09 | 52 Week High | $23.79 | |||
| Open | $10.12 | 52 Week Low | $13.73 | |||
| Day High | $0.09 | P/E | 0.09 | |||
| Day Low | $0.09 | EPS | $1.05 | |||
| Volume | 1,574,031 | |||||

